statistiche ricercatore

Continente	#
NA - Nord America	757
AS - Asia	743
EU - Europa	458
SA - Sud America	35
AF - Africa	26
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.020

Nazione	#
US - Stati Uniti d'America	739
CN - Cina	185
SG - Singapore	181
VN - Vietnam	157
HK - Hong Kong	126
GB - Regno Unito	111
SE - Svezia	86
DE - Germania	61
IT - Italia	41
FR - Francia	32
IN - India	26
UA - Ucraina	25
BR - Brasile	23
RU - Federazione Russa	20
IE - Irlanda	18
KR - Corea	17
NL - Olanda	17
CI - Costa d'Avorio	11
JO - Giordania	11
JP - Giappone	11
CA - Canada	8
FI - Finlandia	8
ZA - Sudafrica	8
BE - Belgio	7
CH - Svizzera	7
HR - Croazia	7
MX - Messico	7
EE - Estonia	6
AR - Argentina	5
TW - Taiwan	5
PH - Filippine	4
PL - Polonia	4
TH - Thailandia	4
BD - Bangladesh	3
ES - Italia	3
ID - Indonesia	3
AT - Austria	2
CO - Colombia	2
EC - Ecuador	2
IR - Iran	2
NG - Nigeria	2
SA - Arabia Saudita	2
TG - Togo	2
A2 - ???statistics.table.value.countryCode.A2???	1
BG - Bulgaria	1
BO - Bolivia	1
CM - Camerun	1
CR - Costa Rica	1
GR - Grecia	1
HN - Honduras	1
IQ - Iraq	1
KN - Saint Kitts e Nevis	1
LK - Sri Lanka	1
MA - Marocco	1
MY - Malesia	1
OM - Oman	1
PK - Pakistan	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
TR - Turchia	1
UY - Uruguay	1
Totale	2.020

Nome	#
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium	271
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.	263
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience	212
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.	208
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.	208
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.	160
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.	155
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma	153
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.	153
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine	149
null	97
Gemcitabine	28
Totale	2.057

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	48	0	0	0	0	0	0	0	0	0	0	14	34
2021/2022	218	19	3	19	27	18	10	3	12	7	19	49	32
2022/2023	278	39	24	11	29	22	22	4	14	68	4	20	21
2023/2024	43	3	9	2	7	6	10	1	2	0	2	0	1
2024/2025	228	2	31	11	13	34	8	12	2	4	25	12	74
2025/2026	753	47	55	57	44	155	74	71	19	145	49	37	0
Totale													2.057

CRIS Current Research Information System